354 related articles for article (PubMed ID: 26337396)
1. Majority of symptoms in esophageal reflux PPI non-responders are not related to reflux.
Roman S; Keefer L; Imam H; Korrapati P; Mogni B; Eident K; Friesen L; Kahrilas PJ; Martinovich Z; Pandolfino JE
Neurogastroenterol Motil; 2015 Nov; 27(11):1667-74. PubMed ID: 26337396
[TBL] [Abstract][Full Text] [Related]
2. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
[TBL] [Abstract][Full Text] [Related]
3. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of proton pump inhibitor-resistant nonerosive reflux disease by esophageal manometry and 24-hour esophageal impedance and pH monitoring.
Kawamura O; Hosaka H; Shimoyama Y; Kawada A; Kuribayashi S; Kusano M; Yamada M
Digestion; 2015; 91(1):19-25. PubMed ID: 25632912
[TBL] [Abstract][Full Text] [Related]
5. Psychosocial Distress and Quality of Life Impairment Are Associated With Symptom Severity in PPI Non-Responders With Normal Impedance-pH Profiles.
Yadlapati R; Tye M; Keefer L; Kahrilas PJ; Pandolfino JE
Am J Gastroenterol; 2018 Jan; 113(1):31-38. PubMed ID: 28895583
[TBL] [Abstract][Full Text] [Related]
6. Increased proximal reflux in a hypersensitive esophagus might explain symptoms resistant to proton pump inhibitors in patients with gastroesophageal reflux disease.
Rohof WO; Bennink RJ; de Jonge H; Boeckxstaens GE
Clin Gastroenterol Hepatol; 2014 Oct; 12(10):1647-55. PubMed ID: 24184737
[TBL] [Abstract][Full Text] [Related]
7. Postprandial High-Resolution Impedance Manometry Identifies Mechanisms of Nonresponse to Proton Pump Inhibitors.
Yadlapati R; Tye M; Roman S; Kahrilas PJ; Ritter K; Pandolfino JE
Clin Gastroenterol Hepatol; 2018 Feb; 16(2):211-218.e1. PubMed ID: 28911949
[TBL] [Abstract][Full Text] [Related]
8. Increasing body weight enhances prevalence and proximal extent of reflux in GERD patients 'on' and 'off' PPI therapy.
Blondeau K; Boecxstaens V; Van Oudenhove L; Farré R; Boeckxstaens G; Tack J
Neurogastroenterol Motil; 2011 Aug; 23(8):724-e327. PubMed ID: 21535319
[TBL] [Abstract][Full Text] [Related]
9. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring.
Mainie I; Tutuian R; Shay S; Vela M; Zhang X; Sifrim D; Castell DO
Gut; 2006 Oct; 55(10):1398-402. PubMed ID: 16556669
[TBL] [Abstract][Full Text] [Related]
10. pH-Impedance Findings and proton pump inhibitors-responsiveness in patients with typical gastroesophageal reflux disease symptoms in a large single-center Italian series.
Vailati C; Mazzoleni G; Testoni PA; Passaretti S
J Clin Gastroenterol; 2014 Aug; 48(7):613-9. PubMed ID: 24326754
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of baseline impedance in patients with proton pump inhibitor-refractory nonerosive reflux disease.
Kohata Y; Fujiwara Y; Yamagami H; Tanigawa T; Shiba M; Watanabe K; Watanabe T; Tominaga K; Arakawa T
J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():36-40. PubMed ID: 25827802
[TBL] [Abstract][Full Text] [Related]
12. Impedance baseline and reflux perception in responder and non-responder non-erosive reflux disease patients.
Ribolsi M; Emerenziani S; Borrelli O; Balestrieri P; Addarii MC; Petitti T; Cicala M
Scand J Gastroenterol; 2012 Nov; 47(11):1266-73. PubMed ID: 22954058
[TBL] [Abstract][Full Text] [Related]
13. Predictors of proton pump inhibitor failure in non-erosive reflux disease: A study with impedance-pH monitoring and high-resolution manometry.
Shi Y; Tan N; Zhang N; Xiong L; Peng S; Lin J; Chen M; Xiao Y
Neurogastroenterol Motil; 2016 May; 28(5):674-9. PubMed ID: 26768192
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with nonresponse to proton pump inhibitors therapy in patients referred for esophageal pH-impedance monitoring.
Garros A; Mion F; Marjoux S; Damon H; Roman S
Dis Esophagus; 2016 Oct; 29(7):787-793. PubMed ID: 25951923
[TBL] [Abstract][Full Text] [Related]
15. 24-hour pH-impedance monitoring on therapy to select patients with refractory reflux symptoms for antireflux surgery. A single center retrospective study.
Desjardin M; Luc G; Collet D; Zerbib F
Neurogastroenterol Motil; 2016 Jan; 28(1):146-52. PubMed ID: 26526815
[TBL] [Abstract][Full Text] [Related]
16. Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease.
Zerbib F; Belhocine K; Simon M; Capdepont M; Mion F; Bruley des Varannes S; Galmiche JP
Gut; 2012 Apr; 61(4):501-6. PubMed ID: 21997546
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of proton-pump inhibitor-refractory non-erosive reflux disease according to multichannel intraluminal impedance-pH monitoring.
Kohata Y; Fujiwara Y; Machida H; Okazaki H; Yamagami H; Tanigawa T; Watanabe K; Watanabe T; Tominaga K; Arakawa T
J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():58-62. PubMed ID: 22486873
[TBL] [Abstract][Full Text] [Related]
18. Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough.
Ribolsi M; Savarino E; De Bortoli N; Balestrieri P; Furnari M; Martinucci I; Casale M; Greco F; Salvinelli F; Savarino V; Marchi S; Cicala M
Aliment Pharmacol Ther; 2014 Oct; 40(8):966-73. PubMed ID: 25109844
[TBL] [Abstract][Full Text] [Related]
19. Postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance can link PPI-responsive heartburn to reflux better than acid exposure time.
Frazzoni L; Frazzoni M; de Bortoli N; Tolone S; Furnari M; Martinucci I; Bertani H; Marchi S; Conigliaro R; Fuccio L; Savarino V; Savarino E
Neurogastroenterol Motil; 2017 Nov; 29(11):. PubMed ID: 28543861
[TBL] [Abstract][Full Text] [Related]
20. GERD phenotypes from pH-impedance monitoring predict symptomatic outcomes on prospective evaluation.
Patel A; Sayuk GS; Kushnir VM; Chan WW; Gyawali CP
Neurogastroenterol Motil; 2016 Apr; 28(4):513-21. PubMed ID: 26686239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
